Imatinib vs Mirvetuximab Soravtansine
Imatinib vs Mirvetuximab Soravtansine: Overview
This comparison examines the pharmacological differences between Imatinib and Mirvetuximab Soravtansine.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Pharmacokinetics
Half-life: Imatinib β 18 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O.
Molecular Weight: Imatinib β 493.6030 g/mol.
Type: Imatinib β Small molecule; Mirvetuximab Soravtansine β Antibody drug conjugate.